Independent biomedical research institute focused on aging
The Buck was a pioneer in research on aging, and now we’re a global leader in the field. We opened our doors in 1999, becoming the world’s only research institution singularly focused on the biology of aging, yielding insights into age-related diseases before they start. We hire scientists from a variety of disciplines to attack the problem from all sides because the answers we’re after won’t come from a single field. To enhance our process, we worked with world-renowned architect I.M. Pei to create a campus that literally would not allow our researchers to work in silos.
Visit website: https://www.buckinstitute.org/
Buck Institute is also referenced in the following:
Developing preventative medicines for age-related disease using ketone bodies
Focused on a novel target linked to one of the fundamental processes of aging
Buck Institute Creations
People at Buck Institute
CEO & President at Buck Institute for Research on Aging.
Professor of biogerontology and Biochemist.
New Zealand/British investor, entrepreneur and philanthropist
Professor at Buck Institute for Age Research.
Director of the Buck Artificial Intelligence Platform & Stanford 1000 Immunomes Project.
Postdoctoral Researcher at Buck Institute for Research on Aging.
Professor at The Buck Institute
Professor at Buck Institute for Research on Aging and CEO of Gerostate Alpha.
Professor at the Buck Institute for Research on Aging.
Research scientist at Buck Institute for Research on Aging
Geriatrician, basic science researcher, and educator at the Buck Institute and the UCSF
Research Assistant Professor at Buck Institute for Research on Aging
Buck Institute News
Immune system clock tracks health, age-related disorders, and longevity
Buck Institute - 12-Jul-2021
Measuring immune health with a chemokine, CXCL9, for early disease interventionsRead more...
First ever non-invasive biomarker test to detect senolysis
Buck Institute - 02-Apr-2021
Detectible senescence-specific biomarker allows development of new drugs for age-related conditionsRead more...
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting yearRead more...
Gerostate Alpha looks at ageing in an unbiased way
Longevity Technology - 20-Jan-2021
Instead of targeting specific hallmarks/pillars - they want to target ageing as a wholeRead more...
A force of tissue stiffness could bring new changes to immune drugs
Buck Institute - 12-Jan-2021
Tissue stiffness alter immune system response to chronic diseases and ageingRead more...
Chronic inflammation promotes NAD+ decline during aging
Buck Institute - 16-Nov-2020
Senescent cells induce NAD+ decline via activation of CD8 macrophagesRead more...
Body builder supplement AKG extends lifespan and healthspan of mice
Buck Institute - 01-Sep-2020
Blood levels fall with age. NUS planning a clinical trial with middle-aged humans.Read more...
How lamins are linked to senescence and ageing
Lifespan.io (LEAF) - 19-Jun-2020
Connections have been elucidated but more research needed to confirm significant linksRead more...
Eating less to live longer? Study in fruit fly finds no benefit
Science Daily - 04-Jun-2020
Life extending benefit of dietary restriction might depend upon genetic makeupRead more...
Comprehensive history and explanation of senescent cells
The Scientist - 01-Mar-2020
Including the latest on clinical trials of first-generation senolyticsRead more...
Underlying mechanisms of how cellular senescence leads to neurodegeneration
Buck Institute - 29-Jan-2020
Cellular senescence is now a top research topic and a very messy one in ageing researchRead more...
SASP Atlas created by team of researchers
Lifespan.io (LEAF) - 28-Jan-2020
It is a comprehensive proteomic database of soluble proteins and exosomal cargo SASP factorsRead more...
Can we treat the ageing process or not? That's the question
UCSF - 02-Jan-2020
John Newman, UCSF asst prof & Buck Institute researcher, explains upcoming ageing interventionsRead more...
Longevity Leaders' latest report on how longevity is disrupting the world
Longevity Leaders (LSX) - 01-Jan-2020
An interesting collection of interviews and white-papers with industry leadersRead more...
Longevity.Technology interviews Buck Institute’s President and CEO Eric Verdin
Longevity Technology - 03-Oct-2019
Includes updates on NAPA Therapeutics and BHB TherapeuticsRead more...
Senolytics for IPF human clinical trial results released
Lifespan.io (LEAF) - 07-Jan-2019
Physical improvements recorded, but pulmonary function was unchcangedRead more...
Aging focused biotechs forms AI based joint venture
FierceBiotech - 14-Aug-2018
Groundbreaking research biotechs performs aging research together for longevityRead more...
SRF has made progress in the fight against ageing
Lifespan.io (LEAF) - 05-Dec-2017
R&D phase in SENS repair approach has shown promising resultsRead more...
Metformin human trials planned
Diabetes.co.uk - 30-Nov-2015
Could significantly increase life expectancy and health span. 20 years ago aging was a biologica...Read more...
Switching off genes could extend lifespan by 60 per cent
Sydney Morning Herald - 12-Oct-2015
238 genes identified that, when silenced, increase the lifespan of yeast cells. Half of these ge...Read more...
Display all news